Effective TAE therapy using Lipiodol with epirubicin for liver metastases of nonfunctioning islet cell carcinoma of the pancreas
| Autor: | Keigo Ashida, Nobuaki Kaibara, Sadamu Takahashi, Takuji Naka, Kiyoaki Mizusawa, Tetsuya Kaneko |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Contrast Media Pancreaticoduodenectomy Hepatic Artery Pancreatectomy Internal medicine Carcinoma Humans Medicine Chemoembolization Therapeutic Epirubicin Antibiotics Antineoplastic Hepatology business.industry Liver Neoplasms Iodized Oil Middle Aged medicine.disease Primary tumor Pancreatic Neoplasms medicine.anatomical_structure Chemotherapy Adjuvant Lipiodol Carcinoma Islet Cell Surgery Radiology Tomography X-Ray Computed business Pancreas medicine.drug |
| Zdroj: | Journal of Hepato-Biliary-Pancreatic Surgery. 5:108-112 |
| ISSN: | 1436-0691 0944-1166 |
| DOI: | 10.1007/s005340050018 |
| Popis: | We report the response of two patients with advanced nonfunctioning islet cell carcinoma of the pancreas with liver metastases treated with a combination of surgi-cal resection and transarterial embolization (TAE), using Lipiodol with epirubicin. After pretreatment evaluation, the two patients were diagnosed with nonfunctioning islet cell carcinoma of the pancreas with liver metastases. Preoperatively, in both patients, TAE was performed through the hepatic arteries, using Lipiodol and sponzel plus epirubicin. Surgical resection of the primary tumor (radical distal pancreatectomy and pancreaticoduodenectomy) was performed. After surgical resection and evaluation of the malignant histopathological features of the neoplasms, chemotherapy, which included oral 5-fluorouracil (FU), and transarterial infusion therapy, using Lipiodol with epirubicin, was administered to the patients. Follow-up evaluation of the two patients by computerized tomography (CT) scan showed a reduction in the size of the metastatic hepatic masses after several chemoembolizations through the hepatic arteries. This combined treatment modality may be an effective therapeutic strategy for improved management of patients with advanced nonfunctioning islet cell carcinoma of the pancreas with liver metastases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink